ITCI
Lazard Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,567
| Closed | -$214K | – | 2624 |
|
|
2024
Q4 | $214K | Sell |
2,567
-196
| -7% | -$16.3K | ﹤0.01% | 1598 |
|
|
2024
Q3 | $201K | Hold |
2,763
| – | – | ﹤0.01% | 1610 |
|
|
2024
Q2 | $188K | Buy |
2,763
+1,766
| +177% | +$120K | ﹤0.01% | 1580 |
|
|
2024
Q1 | $68K | Hold |
997
| – | – | ﹤0.01% | 1654 |
|
|
2023
Q4 | $71K | Hold |
997
| – | – | ﹤0.01% | 1792 |
|
|
2023
Q3 | $51K | Buy |
997
+539
| +118% | +$27.6K | ﹤0.01% | 1850 |
|
|
2023
Q2 | $29K | Buy |
+458
| New | +$29K | ﹤0.01% | 2019 |
|
|
2021
Q4 | – | Sell |
-31,525
| Closed | -$1.18M | – | 2492 |
|
|
2021
Q3 | $1.18M | Buy |
+31,525
| New | +$1.18M | ﹤0.01% | 1037 |
|